Phakic Intraocular Lens Implantation: Refractive Outcome and Safety in Patients with Anterior Chamber Depth between 2.8 and 3.0 versus ≥3.0 mm
| Autor: | Conceição Lobo, Marta Gomes Guerra, Joaquim Murta, João Póvoa, Andreia M.M. Silva, Sofia H. Melo, Sara Homem de Melo Marques |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Adult
Male medicine.medical_specialty Phakic Intraocular Lenses Distance visual acuity Time Factors Anterior Chamber Spherical equivalent Cell Count Phakic intraocular lens Prosthesis Design Refraction Ocular 03 medical and health sciences Cellular and Molecular Neuroscience Young Adult 0302 clinical medicine Lens Implantation Intraocular Ophthalmology medicine Humans In patient 030212 general & internal medicine Retrospective Studies business.industry Significant difference Endothelium Corneal High myopia General Medicine Middle Aged Sensory Systems Treatment Outcome Myopia Degenerative 030221 ophthalmology & optometry Female business Anterior chamber phakic intraocular lens Endothelial surface Follow-Up Studies |
| Zdroj: | Ophthalmic research. 57(4) |
| ISSN: | 1423-0259 |
| Popis: | Purpose: To compare endothelial cell (EC) variation after anterior chamber phakic intraocular lens (AC-pIOL) implantation in highly myopic patients with a preoperative anterior chamber depth (ACD) between 2.8 and 3.0 versus ≥3.0 mm. Methods: A total of 280 eyes submitted to primary AC-pIOL implantation were analyzed. Pre- and postoperative values for uncorrected distance visual acuity, corrected distance visual acuity, spherical equivalent, ACD (endothelial surface), and EC count were collected. The eyes were divided into 2 groups: group A - ACD between 2.8 and 3.0 mm; group B - ACD ≥3.0 mm. Mean global EC loss (ECL) and loss for each ACD group, according to pIOL type, were analyzed. Results: Significant improvement of the spherical equivalent (-11.38 ± 4.57 vs. -0.49 ± 0.79; p = 0.000) and a significant decrease in EC density (2,810.95 ± 343.88 vs. 2,584.09 ± 374.88 cells/mm2; p = 0.000) were noted. The mean annual ECL was -2.19 ± 3.97%. Regarding group A (n = 80), a mean annual ECL of -2.06 ± 3.88% was registered, higher for the Acrysof Cachet® subtype, while group B (n = 200) showed -2.25 ± 4.01% ECL, higher for the Verisyse® subtype. There was no significant difference between the groups (p = 0.96). Conclusions: AC-pIOL implantation significantly improves the spherical equivalent in myopic patients. The mean annual ECL after pIOL implantation was higher in the larger ACD group, but this value was not statistically significant. A 2.8-mm ACD value seems to be a safe cutoff for AC-pIOL implantation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|